JP2024518556A5 - - Google Patents

Info

Publication number
JP2024518556A5
JP2024518556A5 JP2023570167A JP2023570167A JP2024518556A5 JP 2024518556 A5 JP2024518556 A5 JP 2024518556A5 JP 2023570167 A JP2023570167 A JP 2023570167A JP 2023570167 A JP2023570167 A JP 2023570167A JP 2024518556 A5 JP2024518556 A5 JP 2024518556A5
Authority
JP
Japan
Prior art keywords
carboxamide
amino
cyclopropanamide
methylpyridazine
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029105 external-priority patent/WO2022241172A1/en
Publication of JP2024518556A publication Critical patent/JP2024518556A/ja
Publication of JP2024518556A5 publication Critical patent/JP2024518556A5/ja
Pending legal-status Critical Current

Links

JP2023570167A 2021-05-14 2022-05-13 置換ヘテロ環化合物 Pending JP2024518556A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163188498P 2021-05-14 2021-05-14
US63/188,498 2021-05-14
US202263328835P 2022-04-08 2022-04-08
US63/328,835 2022-04-08
PCT/US2022/029105 WO2022241172A1 (en) 2021-05-14 2022-05-13 Substituted heterocyclic compounds

Publications (2)

Publication Number Publication Date
JP2024518556A JP2024518556A (ja) 2024-05-01
JP2024518556A5 true JP2024518556A5 (https=) 2025-05-21

Family

ID=81928155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570167A Pending JP2024518556A (ja) 2021-05-14 2022-05-13 置換ヘテロ環化合物

Country Status (5)

Country Link
US (1) US20240317718A1 (https=)
EP (1) EP4337649A1 (https=)
JP (1) JP2024518556A (https=)
KR (1) KR20240008339A (https=)
WO (1) WO2022241172A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12492184B2 (en) 2020-12-22 2025-12-09 InventisBio Co., Ltd. Heteroaryl compounds, preparation methods and uses thereof
CA3208361A1 (en) 2021-02-19 2022-08-25 Anjali Pandey Tyk2 inhibitors and uses thereof
EP4294806A1 (en) 2021-02-19 2023-12-27 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
AU2022222470A1 (en) 2021-02-19 2023-09-21 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
KR20240008337A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
US11884650B2 (en) * 2021-05-14 2024-01-30 Bristol-Myers Squibb Company Substituted heterocyclic compounds
JP2024518791A (ja) * 2021-05-14 2024-05-02 ブリストル-マイヤーズ スクイブ カンパニー 置換ヘテロ環化合物
WO2024044486A1 (en) * 2022-08-22 2024-02-29 Ajax Therapeutics, Inc. Jak2 inhibitor compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3495358T (lt) * 2012-11-08 2022-05-25 Bristol-Myers Squibb Company Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
CN111936486B (zh) * 2018-03-22 2023-09-22 百时美施贵宝公司 用作IL-12、IL-23和/或IFNα响应的调节剂的包含吡啶的杂环化合物
AU2019373203B2 (en) * 2018-10-30 2024-10-24 Bristol-Myers Squibb Company Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
CN115448910B (zh) * 2019-01-28 2024-04-19 江苏豪森药业集团有限公司 一种哒嗪类衍生物抑制剂、其制备方法和应用
JP7740849B2 (ja) * 2021-05-04 2025-09-17 シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド 含窒素複素環ピリジン化合物
KR20240008337A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
PE20250262A1 (es) * 2021-05-14 2025-01-29 Bristol Myers Squibb Co Compuestos heterociclicos sustituidos
US11884650B2 (en) * 2021-05-14 2024-01-30 Bristol-Myers Squibb Company Substituted heterocyclic compounds
JP2024518791A (ja) * 2021-05-14 2024-05-02 ブリストル-マイヤーズ スクイブ カンパニー 置換ヘテロ環化合物

Similar Documents

Publication Publication Date Title
JP2024518556A5 (https=)
RU2021127810A (ru) Замещенные гетероарилом пиридины и способы применения
CN101410111B (zh) 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
JP2019517455A5 (https=)
JP6017313B2 (ja) 化合物および方法
AU2010302842B2 (en) Novel compounds
JP2007523142A5 (https=)
KR101345497B1 (ko) 설폰아미드 유도체
DK2038265T3 (en) Inhibitors of human protein tyrosine phosphatase and methods of use
RU2392275C2 (ru) Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов
JP2021504443A5 (https=)
JP2008501673A5 (https=)
CA2630269A1 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
RU2005129729A (ru) Производные гетероарилкарбамоилбензола
JP2005513026A5 (https=)
RU2009102537A (ru) Ингибиторы белок-тирозинфосфатазы человека и способы применения
RU2008110949A (ru) Соединения и композиции-иммуносупрессанты
JP2015517580A5 (https=)
JP2004502670A5 (https=)
WO2011060392A1 (en) Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
JP2014523400A5 (https=)
AU2012245082A1 (en) Aromatic amides and uses thereof
JP2010540462A5 (https=)
JP2013531070A5 (https=)
JP2014513122A5 (https=)